Toxic epidermal necrolysis treated with low-dose intravenous immunoglobulin: immunohistoichemical study of Fas and Fas-Ligand expression

被引:13
作者
Ito, K [1 ]
Hara, H [1 ]
Okada, T [1 ]
Shimojima, H [1 ]
Suzuki, H [1 ]
机构
[1] Nihon Univ, Sch Med, Dept Dermatol, Itabashi Ku, Tokyo 1738610, Japan
关键词
D O I
10.1111/j.1365-2230.2004.01635.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:679 / 680
页数:2
相关论文
共 4 条
  • [1] Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis - A prospective noncomparative study showing no benefit on mortality or progression
    Bachot, N
    Revuz, J
    Roujeau, JC
    [J]. ARCHIVES OF DERMATOLOGY, 2003, 139 (01) : 33 - 36
  • [2] Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins - Multicenter retrospective analysis of 48 consecutive cases
    Prins, C
    Kerdel, FA
    Padilla, RS
    Hunziker, T
    Chimenti, S
    Viard, I
    Mauri, DN
    Flynn, K
    Trent, J
    Margolis, DJ
    Saurat, JH
    French, LE
    [J]. ARCHIVES OF DERMATOLOGY, 2003, 139 (01) : 26 - 32
  • [3] Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: Our experience
    Stella, M
    Cassano, P
    Bollero, D
    Clemente, A
    Giorio, G
    [J]. DERMATOLOGY, 2001, 203 (01) : 45 - 49
  • [4] Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
    Viard, I
    Wehrli, P
    Bullani, R
    Schneider, P
    Holler, N
    Salomon, D
    Hunziker, T
    Saurat, JH
    Tschopp, J
    French, LE
    [J]. SCIENCE, 1998, 282 (5388) : 490 - 493